APA (7th ed.) Citation

DA, D., P, D., G, B., R, P., L, A., J, G., . . . AE, V. (2023). Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile. Frontiers in public health, 11, 1229045. https://doi.org/10.3389/fpubh.2023.1229045

Chicago Style (17th ed.) Citation

DA, Díaz-Dinamarca, et al. "Humoral Immunity Against SARS-CoV-2 Evoked by Heterologous Vaccination Groups Using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) Vaccines in Chile." Frontiers in Public Health 11 (2023): 1229045. https://doi.org/10.3389/fpubh.2023.1229045.

MLA (9th ed.) Citation

DA, Díaz-Dinamarca, et al. "Humoral Immunity Against SARS-CoV-2 Evoked by Heterologous Vaccination Groups Using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) Vaccines in Chile." Frontiers in Public Health, vol. 11, 2023, p. 1229045, https://doi.org/10.3389/fpubh.2023.1229045.